论文部分内容阅读
70年代以来,对乙肝病毒(HBV)及慢乙肝的发病机理有较深入的研究,认识到慢乙肝病人肝脏炎症损伤乃免疫机理所致,但HBV持续存在复制是启动慢乙肝病人肝脏炎症持续活动的重要原因。因此,治疗慢乙肝的关键措施是持续地抑制HBV的复制。近年来,在各种抗病毒疗法中,抗病毒药物的研究及其临床应用得到了广泛的重视。现仅就慢乙肝的抗病毒药物治疗情况综述如下。
Since the 1970s, the pathogenesis of hepatitis B virus (HBV) and chronic hepatitis B have been studied in more depth. It is recognized that the inflammatory injury of liver in patients with chronic hepatitis B is caused by the immune mechanism. However, the persistent replication of HBV is the persistent activity of liver inflammation in patients with chronic hepatitis B The important reason. Therefore, the treatment of chronic hepatitis B is the key measure of sustained inhibition of HBV replication. In recent years, a variety of antiviral therapies, antiviral drugs and their clinical application has received widespread attention. Now only chronic hepatitis B antiviral therapy are summarized below.